Connection

Chih-Cheng Lai to Pandemics

This is a "connection" page, showing publications Chih-Cheng Lai has written about Pandemics.
Connection Strength

0.185
  1. The COVID-19 pandemic and tuberculosis in Taiwan. J Infect. 2020 08; 81(2):e159-e161.
    View in: PubMed
    Score: 0.030
  2. COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored. J Microbiol Immunol Infect. 2020 Jun; 53(3):444-446.
    View in: PubMed
    Score: 0.029
  3. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020 Apr; 55(4):105946.
    View in: PubMed
    Score: 0.029
  4. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020 Jun; 53(3):404-412.
    View in: PubMed
    Score: 0.029
  5. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr; 57(4):106324.
    View in: PubMed
    Score: 0.008
  6. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis. Travel Med Infect Dis. 2021 Mar-Apr; 40:101997.
    View in: PubMed
    Score: 0.008
  7. Diagnoses of syphilis and HIV infection during the COVID-19 pandemic in Taiwan. Sex Transm Infect. 2021 06; 97(4):319.
    View in: PubMed
    Score: 0.008
  8. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review. Int J Infect Dis. 2020 Dec; 101:314-322.
    View in: PubMed
    Score: 0.008
  9. In vitro diagnostics of coronavirus disease 2019: Technologies and application. J Microbiol Immunol Infect. 2021 Apr; 54(2):164-174.
    View in: PubMed
    Score: 0.007
  10. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020 Aug; 53(4):505-512.
    View in: PubMed
    Score: 0.007
  11. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106024.
    View in: PubMed
    Score: 0.007
  12. Global coronavirus disease 2019: What has daily cumulative index taught us? Int J Antimicrob Agents. 2020 Jun; 55(6):106001.
    View in: PubMed
    Score: 0.007
  13. Increase in sexually transmitted infection during the COVID-19 pandemic in Taiwan. J Eur Acad Dermatol Venereol. 2021 03; 35(3):e171-e172.
    View in: PubMed
    Score: 0.002
  14. Zero measles after COVID-19 pandemic in Taiwan. J Infect. 2021 03; 82(3):414-451.
    View in: PubMed
    Score: 0.002
  15. Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan. J Infect. 2021 02; 82(2):282-327.
    View in: PubMed
    Score: 0.002
  16. Tocilizumab for severe COVID-19: a systematic review and meta-analysis. Int J Antimicrob Agents. 2020 Sep; 56(3):106103.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.